GlaxoSmithKline plc (ADR) (GSK)
The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.
Recs
richardrogers4
(64.75)
Submitted: 11/14/2009 2:55:30 AM :
Start Price:
$41.71
GSK Score:
+0.43
Defensive picl
Recs
garrodcm
(44.83)
Submitted: 11/2/2009 10:24:16 AM :
Start Price:
$40.31
GSK Score:
-1.30
Good products
Recs
astroboy356
(63.36)
Submitted: 10/16/2009 5:40:14 PM :
Start Price:
$40.71
GSK Score:
+0.55
Do not invest in this company they are bad bad people.
Recs
frtedcrilly
(32.64)
Submitted: 10/7/2009 3:39:23 PM :
Start Price:
$38.84
GSK Score:
+3.40
Aaaah, aaaagh, aaaaaaaagh-choo!
Recs
Recs
icewolfzone
(< 20)
Submitted: 9/2/2009 4:07:34 PM :
Start Price:
$38.41
GSK Score:
-1.39
During H1N1 Mexico outbreak, Fast $ talked @ who made 'antivirals'. GSK was cheaper of two. Bought at $30/sh. Then, GSK one of chosen to develop vaccine.
GSK testing Malaria vaccine on poor African kids. Last news was 50% success in vaccinated Toddlers. GSK stated intent to keep costs very low due to poverty in resources of this group-gave them a score for compassion. Such a bad disease, with only those w/ that horrid 'sickle cell' disease immune.
IMO, GSK will do great by 2020,good 2-5 years, well in 1 yr barring a 'black swan' event! tks
Recs
samstevens
(63.17)
Submitted: 8/20/2009 12:23:45 AM :
Start Price:
$38.61
GSK Score:
-2.27
you dont mess with the big man
Recs
COOLSTOCK
(68.09)
Submitted: 8/17/2009 3:54:05 PM :
Start Price:
$37.80
GSK Score:
-1.73
a global pharma company
Recs
jjluther19
(< 20)
Submitted: 8/12/2009 4:52:47 PM :
Start Price:
$38.45
GSK Score:
-0.58
Way too much of an individual advantage
Recs
zloj
(98.61)
Submitted: 8/9/2009 1:35:24 AM :
Start Price:
$38.56
GSK Score:
-1.44
The Illinois demagogue is very friendly toward Big Pharma.
Recs
TMFTarantula
(68.69)
Submitted: 8/6/2009 3:09:52 AM :
Start Price:
$38.02
GSK Score:
+0.17
Operates with high margins, has good cash generation and a conservative balance sheet. Modest current valuation.
Recs
RNewBuff
(< 20)
Submitted: 8/3/2009 2:10:46 PM :
Start Price:
$41.80
GSK Score:
+5.42
Sirtrius a GSK subsidiary has two drugs coming through clinical trials. If they are as effective against type II diabetes as expected you can expect GSK to add billions to it's bottom line over the next 5 years.
Recs
SmallPimpin
(98.44)
Submitted: 7/31/2009 11:36:32 AM :
Start Price:
$37.79
GSK Score:
-1.38
Mmm...pharmaceuticals...
Recs
VUCommodore
(57.35)
Submitted: 7/16/2009 2:45:03 PM :
Start Price:
$36.02
GSK Score:
-1.18
This Berkshire holding boasts a substantial dividend yield, and has the necessary financial strength to weather a short to medium term "double dip" in the economy.
Recs
AVTX
(< 20)
Submitted: 7/14/2009 9:17:27 PM :
Start Price:
$35.81
GSK Score:
-3.78
H1N1, do I need to say more going to the flu season in a few months.
Recs
USNHR
(97.85)
Submitted: 7/9/2009 4:01:31 PM :
Start Price:
$34.15
GSK Score:
-3.73
Flu season, she is a coming, and with it... H1N1.
Recs
rodvold
(89.94)
Submitted: 7/9/2009 3:46:52 AM :
Start Price:
$34.89
GSK Score:
-5.10
I really need to quit smoking...
Recs
TyrVsGarm
(36.50)
Submitted: 7/6/2009 2:21:03 PM :
Start Price:
$34.24
GSK Score:
+1.48
GlaxoSmithKline has two blockbusters coming off patent in 2010 which will affect the bottom line in the near-term. While GSK has a healthy pipeline, it also is sitting on over $10 Billion worth of currency (most of it in dollars). I suspect that it will try to put some (or all) of this cash to work with an acquisition (to try to further compensate for the loss of Advair and Avandia). Between acquisition costs, taxes to repatriate some of the funds, and any goodwill, I don't believe the imminent acquistion will be accretive until 2011 at the earliest.
Recs
ruinas
(< 20)
Submitted: 7/1/2009 4:38:44 PM :
Start Price:
$34.20
GSK Score:
-0.78
Expect profit taking following recent run-up in market as well as FDA black box warning on anti-smoking drug Zyban/
Recs
StocksForCash
(< 20)
Submitted: 6/30/2009 2:49:49 PM :
Start Price:
$34.47
GSK Score:
+0.75
I just laid on a bunch of shorts and closed most of my longs. Adding some defensive names here as I think we go down starting tomorrow (now that window dressing is done). I could be wrong but I think the next shoe is about to drop ... it might be employment data or commercial real estate ... don't know.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 208 1 2 3 4 5 6 7 8 9 10 Next »